Quest Diagnostics Inc Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
Quest Diagnostics Inc (DGX) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of $5.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-23.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2018-02-23
- Quest Diagnostics Inc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2015 was $5.00M.
- Quest Diagnostics Inc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2014 was -$3.00M, a 400.00% decline from fiscal 2013.
- Quest Diagnostics Inc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2013 was $1.00M.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month |
|---|---|
| 2015-12-31 | $5.00M 10-K · filed 2018-02-23 |
| 2014-12-31 | -$3.00M 10-K · filed 2017-02-22 |
| 2013-12-31 | $1.00M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |